Exhibit 1
Joint Filing Statement
Statement Pursuant to Rule 13d-1(k)(1)
The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, $0.001 Par Value, of Intersect ENT, Inc., beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule 13G.
Dated:June 9, 2020 | Ayrton Capital LLC | |
By: | /s/ Waqas Khatri | |
Name: | Waqas Khatri | |
Title: | Managing Member | |
Alto Opportunity Master Fund SPC – Segregated Master Portfolio B | ||
By: | /s/ Waqas Khatri | |
Name: | Waqas Khatri | |
Title: | Managing Member | |
Ayrton Capital LLC | ||
By: | Waqas Khatri | |
By: | /s/ Waqas Khatri | |
Name: | Waqas Khatri | |
Title: | Managing Member |